Tudor Investment Corp
MRVI icon

Tudor Investment Corp’s Maravai LifeSciences MRVI Stock Holding History

Tudor Investment Corp’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
+396,915
New +$1.35M ﹤0.01% 2281
2021
Q1 		– Sell
-174,735
Closed -$4.9M – 1748
2020
Q4 		$4.9M Buy
+174,735
New +$4.87M 0.14% 145

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tudor Investment Corp's MRVI Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 396,915 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #2281 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in MRVI as recently as Q4 2020.

Tudor Investment Corp first reported a position in MRVI in Q4 2020 and has held it in 2 quarters since. The position peaked at $4.9M in Q4 2020. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Tudor Investment Corp held 396,915 shares of Maravai LifeSciences worth $1.12M as of Q1 2026.
  • Maravai LifeSciences was a new Tudor Investment Corp position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2281 holding.
  • Tudor Investment Corp first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 2 quarters since.
  • Tudor Investment Corp's Maravai LifeSciences position peaked at $4.9M in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.